GlassScriptPhysician profile
Emory C Chang
NPI 1962593962
$225,875.11
in general payments reported to CMS, 2019-2025
19 companies · $47K in 2025
The $47K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $9,624 · 2021: $23K · 2022: $39K · 2023: $42K · 2024: $47K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $105K · Consulting Fee: $18K · Travel and Lodging: $9,878 · Food and Beverage: $2,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $104,723.61 |
| Consulting Fee | $18,284.00 |
| Travel and Lodging | $9,877.95 |
| Food and Beverage | $2,931.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $172,038.85 | 2019-2025 | |
| Spineart USA INC | $24,532.14 | 2022-2025 | Perla Tl, Romeo 2 |
| Globus Medical, INC. | $14,338.44 | 2019-2022 | |
| Orthofix Medical, INC. | $7,191.02 | 2019-2023 | Truelok |
| Seaspine Orthopedics Corporation | $5,606.46 | 2019-2020 | |
| Stryker Corporation | $1,240.43 | 2019-2025 | N/A |
| Zimmer Biomet Holdings, INC. | $256.47 | 2019-2022 | |
| Spineart Sa | $230.90 | 2024 | |
| Merz North America, INC. | $132.00 | 2022 | |
| Mimedx Group, INC. | $80.12 | 2025 | |
| Baxter Healthcare | $51.67 | 2025 | Floseal |
| Zimvie INC. | $33.94 | 2023 | |
| Viiv Healthcare Company | $30.30 | 2021 | |
| Medtronic, INC. | $23.94 | 2022 | |
| Saxum Surgical, INC. | $19.64 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $19.02 | 2025 | |
| Depuy Synthes Sales INC. | $18.34 | 2022 | |
| Biomarin Pharmaceutical INC. | $16.80 | 2022 | |
| Medicrea USA, Corp. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emory Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.